Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.38 | 1.67 |
NAV | ₹20.27 | ₹214.04 |
Fund Started | 14 Jan 2008 | 20 Aug 2004 |
Fund Size | ₹211.91 Cr | ₹15520.74 Cr |
Exit Load | Exit load of 1%, if redeemed within 30 days. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 27.27% | 26.32% |
3 Year | 22.40% | 25.91% |
5 Year | 16.58% | 22.50% |
1 Year
3 Year
5 Year
Equity | 94.65% | 83.32% |
Cash | 5.35% | 16.35% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 7.22% |
HDFC Bank Ltd. | 5.59% |
Infosys Ltd. | 4.92% |
Canara Bank | 4.77% |
REC Ltd. | 4.47% |
ABB India Ltd. | 4.45% |
Amber Enterprises India Ltd. | 4.01% |
Bharat Electronics Ltd. | 3.86% |
PB Fintech Ltd. | 3.77% |
Zomato Ltd. | 3.63% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.49% |
ICICI Bank Ltd. | 9.21% |
Axis Bank Ltd. | 8.35% |
Maruti Suzuki India Ltd. | 4.46% |
SBI Life Insurance Company Ltd. | 4.17% |
Cipla Ltd. | 4.15% |
Kotak Mahindra Bank Ltd. | 3.98% |
HCL Technologies Ltd. | 3.81% |
Bharti Airtel Ltd. | 3.67% |
Piramal Pharma Ltd. | 3.64% |
Name | Satish Ramanathan | Dhruv Muchhal |
Start Date | 01 Oct 2024 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation/income by investing in equity and equity related instruments across market capitalization of up to 30 companies. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 14 Jan 2008 | 20 Aug 2004 |
Description
Launch Date